Stephanie Earnshaw

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Filter by Type

Filter by Year

Search Results

Budget impact analysis: review of the state of the art

The computing framework and calculations

Reporting budget-impact analyses

Assessing the cost-effectiveness of immunomodulatory therapies for relapsing-remitting multiple sclerosis based on long-term data

Cost-effectiveness of maintaining daily intake of oat β-glucan for coronary heart disease primary prevention

Lifetime cost-effectiveness of calcineurin inhibitor withdrawal after de novo renal transplantation

Validation

The cost-effectiveness of ibandronate in the treatment of postmenopausal osteoporosis in the US

Cardiovascular genetic risk testing for targeting statin therapy in the primary prevention of cardiovascular disease: A cost-effectiveness analysis

Economic comparison of an empirical versus diagnostic-driven strategy for treating invasive fungal disease in immunocompromised patients

Spillover adherence effects of fixed-dose combination HIV therapy

Aspirin for the primary prevention of cardiovascular disease in women: A cost-utility analysis

Response to McGirr et al.'s Comment on "Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada"

Cost-effectiveness of lubiprostone in a managed care population with chronic idiopathic constipation

Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model

Cost effectiveness of chemoprevention for prostate cancer with dutasteride in a high-risk population based on results from the REDUCE clinical trial

Comparative evaluation of patients newly initiating first-generation versus second-generation tyrosine kinase inhibitors for chronic myeloid leukemia and medication adherence, health services utilization, and healthcare costs

Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis

Cost-effectiveness of 13-valent pneumococcal conjugate vaccine: Germany, Greece, and The Netherlands

A cost-effectiveness analysis of antibiotic therapy in macrolide-resistant community-acquired pneumonia